BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

317 related articles for article (PubMed ID: 7625729)

  • 1. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity.
    Muhn P; Fuhrmann U; Fritzemeier KH; Krattenmacher R; Schillinger E
    Ann N Y Acad Sci; 1995 Jun; 761():311-35. PubMed ID: 7625729
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drospirenone: a novel progestogen with antimineralocorticoid and antiandrogenic activity. Pharmacological characterization in animal models.
    Muhn P; Krattenmacher R; Beier S; Elger W; Schillinger E
    Contraception; 1995 Feb; 51(2):99-110. PubMed ID: 7750297
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The novel progestin drospirenone and its natural counterpart progesterone: biochemical profile and antiandrogenic potential.
    Fuhrmann U; Krattenmacher R; Slater EP; Fritzemeier KH
    Contraception; 1996 Oct; 54(4):243-51. PubMed ID: 8922878
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Conception and pharmacodynamic profile of drospirenone.
    Elger W; Beier S; Pollow K; Garfield R; Shi SQ; Hillisch A
    Steroids; 2003 Nov; 68(10-13):891-905. PubMed ID: 14667981
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Progestogens with antimineralocorticoid activity.
    Losert W; Casals-Stenzel J; Buse M
    Arzneimittelforschung; 1985; 35(2):459-71. PubMed ID: 4039568
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Drospirenone--a new progestogen with antimineralocorticoid activity, resembling natural progesterone.
    Oelkers W
    Eur J Contracept Reprod Health Care; 2000 Dec; 5 Suppl 3():17-24. PubMed ID: 11246598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacology of different progestogens: the special case of drospirenone.
    Sitruk-Ware R
    Climacteric; 2005 Oct; 8 Suppl 3():4-12. PubMed ID: 16203650
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antimineralocorticoid activity of a novel oral contraceptive containing drospirenone, a unique progestogen resembling natural progesterone.
    Oelkers W
    Eur J Contracept Reprod Health Care; 2002 Dec; 7 Suppl 3():19-26; discussion 42-3. PubMed ID: 12659403
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nestorone: a progestin with a unique pharmacological profile.
    Kumar N; Koide SS; Tsong Y; Sundaram K
    Steroids; 2000; 65(10-11):629-36. PubMed ID: 11108869
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nomegestrol acetate: steroid receptor transactivation profile in Chinese hamster ovary cells and ovulation inhibition in rat and monkey.
    van Diepen HA; Lam TW; Kuil CW
    Contraception; 2011 Aug; 84(2):199-204. PubMed ID: 21757063
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dihydrospirorenone, a new progestogen with antimineralocorticoid activity: effects on ovulation, electrolyte excretion, and the renin-aldosterone system in normal women.
    Oelkers W; Berger V; Bolik A; Bähr V; Hazard B; Beier S; Elger W; Heithecker A
    J Clin Endocrinol Metab; 1991 Oct; 73(4):837-42. PubMed ID: 1890155
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Drospirenone: pharmacology and pharmacokinetics of a unique progestogen.
    Krattenmacher R
    Contraception; 2000 Jul; 62(1):29-38. PubMed ID: 11024226
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evolution of progestins. Focus on the novel progestin drospirenone.
    Thorneycroft IH
    J Reprod Med; 2002 Nov; 47(11 Suppl):975-80. PubMed ID: 12497671
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Drospirenone: a new cardiovascular-active progestin with antialdosterone and antiandrogenic properties.
    Rübig A
    Climacteric; 2003 Oct; 6 Suppl 3():49-54. PubMed ID: 15018248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preclinical pharmacological profile of nomegestrol acetate, a synthetic 19-nor-progesterone derivative.
    van Diepen HA
    Reprod Biol Endocrinol; 2012 Oct; 10():85. PubMed ID: 23043680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Drospirenone in combination with estrogens: for contraception and hormone replacement therapy.
    Oelkers WH
    Climacteric; 2005 Oct; 8 Suppl 3():19-27. PubMed ID: 16203652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the novel progestin gestodene by receptor binding studies and transactivation assays.
    Fuhrmann U; Slater EP; Fritzemeier KH
    Contraception; 1995 Jan; 51(1):45-52. PubMed ID: 7750284
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Drospirenone, a progestogen with antimineralocorticoid properties: a short review.
    Oelkers W
    Mol Cell Endocrinol; 2004 Mar; 217(1-2):255-61. PubMed ID: 15134826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of the substitution of 11-methylene, delta(15), and/or 18-methyl groups in norethisterone on receptor binding, transactivation assays and biological activities in animals.
    Deckers GH; Schoonen WG; Kloosterboer HJ
    J Steroid Biochem Mol Biol; 2000 Oct; 74(3):83-92. PubMed ID: 11086227
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The pharmacological profile of a novel norpregnance progestin (trimegestone).
    Philibert D; Bouchoux F; Degryse M; Lecaque D; Petit F; Gaillard M
    Gynecol Endocrinol; 1999 Oct; 13(5):316-26. PubMed ID: 10599548
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.